Brokerages Set Ardent Health Partners, LLC (NYSE:ARDT) Price Target at $21.18

Shares of Ardent Health Partners, LLC (NYSE:ARDTGet Free Report) have earned a consensus rating of “Buy” from the twelve analysts that are presently covering the firm, MarketBeat Ratings reports. Two investment analysts have rated the stock with a hold recommendation, eight have assigned a buy recommendation and two have given a strong buy recommendation to the company. The average 1-year price objective among analysts that have issued a report on the stock in the last year is $21.18.

Several research analysts have recently weighed in on the stock. Royal Bank of Canada lowered their price target on shares of Ardent Health Partners from $23.00 to $21.00 and set an “outperform” rating on the stock in a research report on Tuesday, March 4th. Morgan Stanley decreased their target price on shares of Ardent Health Partners from $23.50 to $22.00 and set an “overweight” rating on the stock in a report on Tuesday, January 21st. Stephens restated an “overweight” rating and set a $22.00 price target on shares of Ardent Health Partners in a report on Wednesday. JPMorgan Chase & Co. reaffirmed a “neutral” rating and set a $20.00 price target on shares of Ardent Health Partners in a research report on Tuesday, December 17th. Finally, Truist Financial lowered their price objective on Ardent Health Partners from $22.00 to $21.00 and set a “buy” rating for the company in a research report on Monday, January 6th.

Read Our Latest Report on Ardent Health Partners

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently modified their holdings of the company. Point72 Asia Singapore Pte. Ltd. acquired a new position in Ardent Health Partners during the 4th quarter worth about $27,000. US Bancorp DE acquired a new stake in shares of Ardent Health Partners during the fourth quarter worth about $31,000. R Squared Ltd acquired a new stake in shares of Ardent Health Partners during the fourth quarter worth about $37,000. BNP Paribas Financial Markets purchased a new position in shares of Ardent Health Partners in the third quarter valued at approximately $42,000. Finally, New York State Common Retirement Fund acquired a new position in shares of Ardent Health Partners in the fourth quarter valued at approximately $48,000.

Ardent Health Partners Trading Up 0.3 %

ARDT stock opened at $13.15 on Tuesday. The company has a current ratio of 1.91, a quick ratio of 1.78 and a debt-to-equity ratio of 0.78. The firm has a 50-day moving average of $14.43 and a two-hundred day moving average of $16.28. Ardent Health Partners has a 12 month low of $12.87 and a 12 month high of $20.72.

Ardent Health Partners (NYSE:ARDTGet Free Report) last posted its quarterly earnings results on Wednesday, February 26th. The company reported $0.81 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.50 by $0.31. The company had revenue of $1.61 billion during the quarter, compared to analysts’ expectations of $1.48 billion. As a group, equities research analysts expect that Ardent Health Partners will post 1.23 EPS for the current fiscal year.

Ardent Health Partners Company Profile

(Get Free Report

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.

Recommended Stories

Analyst Recommendations for Ardent Health Partners (NYSE:ARDT)

Receive News & Ratings for Ardent Health Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ardent Health Partners and related companies with MarketBeat.com's FREE daily email newsletter.